Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.
Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...
Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...
The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...
With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.
BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...
Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.
Alia Bhatt and Ranbir Kapoor welcomed a beautiful baby girl Raha in 2022. For women, gaining weight during pregnancy is ...
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results